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Voluntary physical activities are known to modulate anxiety and depressive/like behaviors in both animals and humans. Brain
derived neurotrophic factor (BDNF), has been reported to be elevated following exercise. BDNF, as well as type 2 corticotrophin
releasing factor receptor (CRFR) 2, has been shown to mediate anxiety-like behavior. In the present study we examined the eﬀects
of long-term voluntary exercise on the transcripts for BDNF and CRFR2 in the lateral septum (LS) and for CRF in the central
amygdala (CeA) in female mice. Thus, increased activity of CRF in the CeA is associated with anxiety-like behavior. Quantitative
RT-PCR was employed to measure levels of mRNA in punch biopsies from LS and CeA. In addition, measurements of the
concentration of corticosterone and leptin in plasma were employed. In the LS, we found a three-fold increase of BDNF mRNA
(P<0.05) but no signiﬁcant change in CRFR2 mRNA. No changes in CRF in the amygdala were observed but we found a decrease
in the levels of plasma corticosterone. Plasma leptin and the weight of perigonadal fat pads were decreased following exercise. In
conclusion, these data show that BDNF gene expression in the LS is inﬂuenced by long-term exercise in females but not CRFR2.
1.Introduction
Voluntary exercise has been found to mitigate harmful con-
sequencesofstressonthebrainandtopreventtheexpression
of depression and anxiety-like behavior [1]. Increased activ-
ity of brain-derived neurotrophic factor (BDNF) signaling is
suggested to be an important factor mediating the beneﬁts
seen after running. In agreement, stress and depression have
been found to decrease BDNF expression [2, 3].
Corticotrophin-releasingfactor(CRF)isthemajorhypo-
thalamic mediator of stress and is also involved in the etiol-
ogy of depression and anxiety-like behavior [4, 5] and has
been found to be downregulated in the mouse hypothalamus
following exercise [6, 7]. CRF acts through the seven
transmembrane, G-protein-coupled receptor CRF receptor
1 (CRFR1), initiating the release of cortisol in humans and
corticosterone in rodents from the adrenal gland [8]. The
cloning of a second CRF receptor (CRFR2) [9–11], existing
as two primary splice variants (CRFR2α and CRFR2β), was
followed by the discovery of three additional CRF family
members, the urocortin 1 (Ucn1) [12] ,u r o c o r t i n2( U c n2 )
[13, 14], and urocortin 3 (Ucn 3) [15]. In general, there is
a limited overlap in the distribution of CRF and the CRF
receptor subtypes and of the urocortins, suggesting separate
but complementary functional roles [16]. The physiological
roles of CRFR2 in the brain are still somewhat elusive, but
most reports in the literature suggest involvement in damp-
ening the body’s response to stress. Thus, mice deﬁcient in
CRFR2 (CRFR2 −/−) exposed to restraint stress show rapid
and elevated ACTH levels compared to control animals, and
behavioral studies show an increase in anxiety-like behaviors
[4],possiblyduetoincreasedCRFmRNAlevelsinthecentral
nucleusoftheamygdala.However,studiesusingagonistsand
antagonists against CRFR2 indicate that the attenuation of
depression and anxiety-like behavior in relation to activated
CRFR2 is complex. Thus, the eﬀects has been found to
be diverse, site speciﬁc, and depending on the stress level
and experimental model as well as being diﬀerent between
genders [17].2 International Journal of Peptides
The lateral septum (LS), a brain area important in the
shaping of coping responses to stress and found to modulate
the activity in the amygdala [18], exhibits the highest density
of CRF2 in the brain [16]. Here, we have studied CRFR2 and
BDNF in the female mouse LS using quantitative real-time
reverse transcriptase polymerase chain reaction (qRT-PCR)
in an exercise paradigm. Brain punch biopsies from young
female mice exposed to voluntary exercise and nonexercised
age- and sex-matched controls were analyzed for expression
levels of transcript for BDNF and CRFR2 in LS. In addition,
CRF mRNA was studied in the central nucleus of amygdala
(CeA), as this is a key site for the integration of central stress
circuits.
Finally, we monitored the exercise-induced eﬀects on
morning corticosterone and leptin levels in plasma as well
as the weight of abdominal fat mass.
2.MaterialsandMethods
The experiment was performed in 20 na¨ ıve, 5-week-old
C57/BL6 female mice (Scanbur, Sollentuna, Sweden). All
experimental procedures in animals were approved by the
Animal Care and Use Committee at Link¨ oping University
and in accordance with the European Communities Council
Directive guidelines. The mice were housed individually
under standard conditions with free access to water and food
under a 12-h light and 12-h dark cycle (lights on at 07:00
am). The experimental groups (n = 10) had access to a
wheel (∅:13cm) for three weeks, and the housing of the
control group (n = 10) remained unchanged. The mice
were handled every other day by the examiner to decrease
stress. Vaginal smears were used to assess the stage in the
estrous cycle and all females were in the estrous phase at the
end point of the experiment. The amount of running was
on average 8,000 revolutions per day with peaks during the
proestrus phase.
For analysis of gene expression by qRT-PCR, the mice
were euthanized after three weeks at 9.00 am by means of
decapitation. Blood was immediately withdrawn from the
right ventricle by heart puncture, collected in EDTA con-
tainers (Sarstedt AB, Landskrona, Sweden) and centrifuged
at 7,000×g( 4 ◦C; 10min). The brains were dissected out,
sliced, and put on ice, and punch biopsies were collected
under a microscope using an air-powered punching machine
following a microdissection protocol. The biopsies were
snap-frozen on dry ice and stored at −70◦C. The remaining
slices were frozen for staining and anatomical localization
of the biopsies. Total RNA was extracted using RNeasy Lipid
Tissue Mini Kit (Qiagen, Sollentuna, Sweden)—including
DNase treatment—and RNA was reversely transcribed to
cDNA (Applied Biosystems, Foster City, Calif, USA). Quality
c o n t r o lo fR N Ae x t r a c t i o nw a sp e r f o r m e do ne a c hb r a i n
area using the Agilent RNA 6000 Nano Assay Protocol
(http://www.agilent.com/chem/labonachip/) according to
their protocol.
Real-time RT-PCR was performed on an Applied Biosys-
tems 7900 Fast Real-Time PCR System using TaqMan Fast
Universal PCR Master Mix according to the manufacturer’s
instructions (Applied Biosystems, Stockholm, Sweden). The
TaqMan Gene Expression assays used were: BDNF = Mm
01334042-m1; CRFR2 = Mm 00438303-m1; B-actin =
Mm 00607939-s1 and GAPDH = Mm 99999915-S1 as
endogenous controls. Gene expression was calculated using
the ΔΔCt method (Ct = threshold cycle). Each gene was
normalized with the corresponding average of B-actin and
GAPDH expression in the same animal and expressed as the
fold diﬀerence in relation to the control group.
Morning corticosterone was measured by means of an
enzyme immunoassay (OC-TEIA), according to the ma-
nufacturer’s instruction (IDS Nordic, Herlev, Denmark).
Assay sensitivity was 0.55ng/mL. Leptin concentration was
measured by means of bead-based xMAP Luminex Technol-
ogy (Austin, Tex, USA), using a commercially available kit
(Electrabox, Tyres¨ o, Sweden) according to the manufactures
protocol. Data were acquired as mean ﬂuorescence intensity,
collected by the Star Station software program (Applied
Cytometry Systems, Dinnington, Sheﬃeld, UK). The detec-
tion limit for leptin was 3.0pg/mL.
All statistical analyses were performed in Statistica 10.
For comparisons between several groups, data were analyzed
with ANOVA followed by Student’s t-test to ascertain which
group diﬀered signiﬁcantly from controls. A value of P<
0.05 was considered signiﬁcant.
3. Results and Discussion
Here, we report a 3-fold increase in BDNF gene-expression
levels in the LS following three weeks of voluntary running
(P<0.05) (Figure 1). To our knowledge, this is the ﬁrst
demonstration that BDNF mRNA levels in the female
LS are markedly increased following long-term exercise.
BDNF has a multitude of actions on neurons [19], and
dysfunction of this neurotrophin may modulate mood [2].
Exercise has been found to induce BDNF-mediated increase
of neurogenesis [20], and increased BDNF gene-expression
and protein following acute or long-term exercise results
in mood beneﬁts and enhanced memory [3, 21]. However,
studies of exercise-induced eﬀects on BDNF in other brain
areas and circuits other than hippocampus are limited. In
addition, we studied the eﬀect after voluntary exercise on
CRFR2, since the LS harbors substantial levels of CRFR2
[16] and since this receptor has been reported to mediate
coping responses during the recovery phase after stress
[4, 22]. In the present study, CRFR2 gene-expression was,
however, not altered after three weeks exercise nor was CeA
expressionofCRFmRNAalthoughwefoundatrendtowards
an increase in CRFR2 (Figure 1). Plasma concentrations of
morning corticosterone were decreased by approximately
18% compared to the control group (15,3 ± 1,6ng/mL;
12,6 ± 2,4ng/mL, P<0.01) (Figure 2), which may suggests
that it is possible that a part of the HPA-axis is inhibited
by voluntary long-term exercise. However, this needs to be
clariﬁed. We used female mice, since anxiety and depression
are twice as common in females, and there is accumulating
evidence that the CRF system also outside hypothalamus
is diﬀerently regulated when comparing female and maleInternational Journal of Peptides 3
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Figure 1: The ﬁgure represents the gene expression employed by quantitative real-time PCR (Q-RT-PCR), of brain derived neurotrophic
factor (BDNF) (a), corticotrophin-releasing factor receptor 2 (b) in the lateral septum (LS), and corticotrophin releasing factor (CRF) in the
central amygdala (CeA) following three weeks voluntary exercise (c). Q-RT-PCR of the full-length BDNF demonstrated a signiﬁcant, 3-fold
upregulation in the LS after three weeks of running compared to controls (P<0.05). No signiﬁcant changes in CRFR2 (LS) or CRF (CeA)
gene expression were observed.
rodents [23]. The amount of voluntary running in females is
closely correlated to the levels of sex hormones. We observed
what others also have found that the average frequency of
running where higher during the proestrus phase when there
is a peak in estrogen levels [24]. We chose to collect the
brains the day at estrus when estrogen levels are low, since
it is known that BDNF is regulated by this sex hormone
itself at least in the hippocampus. Thus, BDNF-synthesizing
neurons express estrogen receptors, and the BDNF gene
contains an estrogen responsive element, suggesting pos-
sible interactions between estrogen and BDNF regulation
[25, 26].
Our working hypothesis was that since acute exercise
initiates the activation of the HPA-axis, CRFR2 might
be activated to counteract the CRF/CRFR1 system in the
amygdala through the LS. Thus, the activation of the CRF
system in the amygdala is tightly correlated to stress and
anxiety-like behavior [27]. However, neither CRFR2 nor
CRF mRNA were changed after three weeks running. Taken
together, if CRFR2 and LS are involved in the strategies of
stress coping, it seems that long-term voluntary exercise is a
situation when LS CRFR2 and CeA CRF are not activated.
The total body weight of the animals did not change after
running. However, we found a decrease of plasma leptin by
60% (P<0.05) (Figure 2), in parallel with a 30% reduction
in fat mass (P<0.001). Food intake and water consumption
was not measured in the present study, but previous studies
of mice using the same experimental model showed no
diﬀerenceinfoodintakeinexercisedanimalsversuscontrols,
and no diﬀerence between groups in total body weight [6],
similar to what we observed. Leptin is a 16kDa protein
hormone and a product of the obese gene that has been
found to be correlated with the lipid content of the cells and
plays an important role in regulating food intake and energy
expenditure. It has been shown in both humans and mice
that weight loss is associated with a decrease in plasma leptin
[28]. As already mentioned, we did not observe any changes
in total body weight but a decrease in perigonadal fat pads.
A decrease in abdominal fat in combination with no weight
l o s si sp r o b a b l yd u et oa ni n c r e a s ei nm u s c l ew e i g h ta f t e r4 International Journal of Peptides
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Figure 2: The ﬁgure represents plasma levels of corticosterone (a) and leptin (pg/mL) (b) following three weeks voluntary exercise.
Corticosterone decreased by 18% in the female runners (P<0.01) and leptin by 60% (P<0.05).
long-term exercise. It is possible that the decrease of plasma
leptin in the present study is correlated to the decrease in
perigonadal fat. However, further studies are needed, since
the mechanisms responsible for regulating leptin expression
andproteinarecomplexandnotfullyunderstoodatleastnot
in females.
In summary, these data show for the ﬁrst time that long-
term voluntary exercise increases BDNF gene expression but
not CRFR2 in the LS or CRF in the CeA in young healthy
female mice. Although our data show that the BDNF gene
is activated by exercise in the LS, the limitation is that we
did not measure BDNF protein levels. However, it is possible
that exercise may promote LS neuronal survival through
increased BDNF, but this needs to be further elucidated.
In addition, to what extent this is related to an eﬀect on
depressive and anxiety-like behavior remains to be analyzed
and would be an intriguing future perspective.
Conﬂict of Interests
The authors declare that there is no conﬂict of interests re-
lated to the study.
Acknowledgments
This work was supported by the County Council in
¨ Osterg¨ otland and the LION’s Foundation, Sweden, for
endemic modern Western illnesses.
References
[1] A. Str¨ ohle, “Physical activity, exercise, depression and anxiety
disorders,” Journal of Neural Transmission, vol. 116, no. 6, pp.
777–784, 2009.
[ 2 ] R .S .D u m a na n dL .M .M o n t e g gi a ,“ An e u r o t r o p h i cm o d e lf o r
stress-related mood disorders,” Biological Psychiatry, vol. 59,
no. 12, pp. 1116–1127, 2006.
[3] R. S. Duman, “Neurotrophic factors and regulation of mood:
role of exercise, diet and metabolism,” Neurobiology of Aging,
vol. 26, pp. S88–S93, 2005.
[4] T. L. Bale, A. Contarino, G. W. Smith et al., “Mice deﬁcient for
corticotropin-releasing hormone receptor-2 display anxiety-
like behaviour and are hypersensitive to stress,” Nature
Genetics, vol. 24, no. 4, pp. 410–414, 2000.
[5] W. Vale, J. Spiess, C. Rivier, and J. Rivier, “Characterization
of a 41-residue ovine hypothalamic peptide that stimulates
secretion of corticotropin and β-endorphin,” Science, vol. 213,
no. 4514, pp. 1394–1397, 1981.
[ 6 ]S .K .D r o s t e ,A .G e s i n g ,S .U l b r i c h t ,M .B .M ¨ uller, A. C.
E. Linthorst, and J. M. H. M. Reul, “Eﬀects of long-term
voluntary exercise on the mouse hypothalamic-pituitary-
adrenocortical axis,” Endocrinology, vol. 144, no. 7, pp. 3012–
3023, 2003.
[7] S. K. Droste, M. C. Schweizer, S. Ulbricht, and J. M. H.
M. Reul, “Long-term voluntary exercise and the mouse
hypothalamic-pituitary-adrenocortical axis: impact of con-
current treatment with the antidepressant drug tianeptine,”
Journal of Neuroendocrinology, vol. 18, no. 12, pp. 915–925,
2006.
[8] R. Chen, K. A. Lewis, M. H. Perrin, and W. W. Vale,
“Expression cloning of a human corticotropin-releasing-
factor receptor,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 90, no. 19, pp.
8967–8971, 1993.
[9] T. Kishimoto, R. V. Pearse, C. R. Lin, and M. G. Rosenfeld,
“Asauvagine/corticotropin-releasingfactorreceptorexpressed
in heart and skeletal muscle,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 92, no.
4, pp. 1108–1112, 1995.
[10] T. W. Lovenberg, C. W. Liaw, D. E. Grigoriadis et al., “Cloning
and characterization of a functionally distinct corticotropin-
releasing factor receptor subtype from rat brain,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 92, no. 3, pp. 836–840, 1995.
[11] M. Perrin, C. Donaldson, R. Chen et al., “Identiﬁcation of
a second corticotropin-releasing factor receptor gene and
characterization of a cDNA expressed in heart,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 92, no. 7, pp. 2969–2973, 1995.
[12] J. Vauhan, C. Donaldson, J. Bittencourt et al., “Urocortin, a
mammalian neuropeptide related to ﬁsh urotensin I and toInternational Journal of Peptides 5
corticotropin-releasing factor,” Nature, vol. 378, no. 6554, pp.
287–292, 1995.
[13] S. Y. Hsu and A. J. W. Hsueh, “Human stresscopin and
stresscopin-related peptide are selective ligands for the type 2
corticotropin-releasing hormone receptor,” Nature Medicine,
vol. 7, no. 5, pp. 605–611, 2001.
[14] T. M. Reyes, K. Lewis, M. H. Perrin et al., “Urocortin
II: a member of the corticotropin-releasing factor (CRF)
neuropeptide family that is selectively bound by type 2 CRF
receptors,” Proceedings of the National Academy of Sciences of
the United States of America, vol. 98, no. 5, pp. 2843–2848,
2001.
[15] K. Lewis, C. Li, M. H. Perrin et al., “Identiﬁcation of urocortin
III,anadditionalmemberofthecorticotropin-releasingfactor
(CRF) family with high aﬃnity for the CRF2 receptor,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 98, no. 13, pp. 7570–7575, 2001.
[16] K. van Pett, V. Viau, J. C. Bittencourt et al., “Distribution of
mRNAs encoding CRF receptors in brain and pituitary of rat
and mouse,” Journal of Comparative Neurology, vol. 428, no. 2,
pp. 191–212, 2000.
[17] T.L.Bale,“Sensitivitytostress:dysregulationofCRFpathways
anddiseasedevelopment,”HormonesandBehavior,vol.48,no.
1, pp. 1–10, 2005.
[18] Y. H. Li and Y. H. Ku, “Involvement of rat lateral septum-
acetylcholine pressor system in central amygdaloid nucleus-
emotional pressor circuit,” Neuroscience Letters, vol. 323, no.
1, pp. 60–64, 2002.
[19] G. R. Lewin and Y. A. Barde, “Physiology of the neu-
rotrophins,” Annual Review of Neuroscience, vol. 19, pp. 289–
317, 1996.
[20] F. G´ omez-Pinilla, Z. Ying, R. R. Roy, R. Molteni, and V.
R. Edgerton, “Voluntary exercise induces a BDNF-mediated
mechanism that promotes neuroplasticity,” Journal of Neuro-
physiology, vol. 88, no. 5, pp. 2187–2195, 2002.
[21] H. van Praag, G. Kempermann, and F. H. Gage, “Running
increases cell proliferation and neurogenesis in the adult
mouse dentate gyrus,” Nature Neuroscience,v o l .2 ,n o .3 ,p p .
266–270, 1999.
[22] T. Kishimoto, J. Radulovic, M. Radulovic et al., “Deletion of
Crhr2 reveals an anxiolytic role for corticotropin-releasing
hormone receptor-2,” Nature Genetics, vol. 24, no. 4, pp. 415–
419, 2000.
[ 2 3 ]D .A .B a n g a s s e r ,A .C u r t i s ,B .A .S .R e y e se ta l . ,“ S e x
diﬀerences in corticotropin-releasing factor receptor signaling
and traﬃcking: potential role in female vulnerability to stress-
related psychopathology,” Molecular Psychiatry, vol. 15, no. 9,
pp. 896–904, 2010.
[24] M. Steiner, R. J. Katz, and B. J. Carroll, “Detailed analy-
sis of estrous-related changes in wheel running and self-
stimulation,” Physiology and Behavior, vol. 28, no. 1, pp. 201–
204, 1982.
[25] R. C. Miranda, F. Sohrabji, and C. D. Toran-Allerand,
“Presumptive estrogen target neurons express mRNAs for
both the neurotrophins and neurotrophin receptors: a basis
for potential developmental interactions of estrogen with the
neurotrophins,” Molecular and Cellular Neurosciences, vol. 4,
no. 6, pp. 510–525, 1993.
[26] H. E. Scharfman and N. J. MacLusky, “Estrogen and brain-
derived neurotrophic factor (BDNF) in hippocampus: com-
plexity of steroid hormone-growth factor interactions in the
adult CNS,” Frontiers in Neuroendocrinology,v o l .2 7 ,n o .4 ,p p .
415–435, 2006.
[27] R. Ciccocioppo, D. R. Gehlert, A. Ryabinin et al., “Stress-
related neuropeptides and alcoholism: CRH, NPY, and
beyond,” Alcohol, vol. 43, no. 7, pp. 491–498, 2009.
[28] M.Maﬀei,J.Halaas,E.Ravussinetal.,“Leptinlevelsinhuman
and rodent: measurement of plasma leptin and ob RNA in
obese and weight-reduced subjects,” Nature Medicine, vol. 1,
no. 11, pp. 1155–1161, 1995.